Northern Trust Corp Has $8.39 Million Stock Position in Avanos Medical, Inc. (NYSE:AVNS)

Northern Trust Corp lifted its stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 4.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 526,763 shares of the company's stock after purchasing an additional 24,720 shares during the quarter. Northern Trust Corp owned about 1.15% of Avanos Medical worth $8,386,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Barclays PLC boosted its stake in Avanos Medical by 446.2% during the 3rd quarter. Barclays PLC now owns 96,194 shares of the company's stock valued at $2,311,000 after purchasing an additional 78,583 shares in the last quarter. JPMorgan Chase & Co. increased its position in Avanos Medical by 6.9% during the third quarter. JPMorgan Chase & Co. now owns 69,571 shares of the company's stock worth $1,672,000 after buying an additional 4,472 shares during the last quarter. Tributary Capital Management LLC grew its position in shares of Avanos Medical by 38.1% in the fourth quarter. Tributary Capital Management LLC now owns 893,008 shares of the company's stock valued at $14,217,000 after purchasing an additional 246,379 shares during the last quarter. Empowered Funds LLC grew its position in shares of Avanos Medical by 141.3% in the fourth quarter. Empowered Funds LLC now owns 153,834 shares of the company's stock valued at $2,449,000 after purchasing an additional 90,091 shares during the last quarter. Finally, New York State Teachers Retirement System grew its position in shares of Avanos Medical by 4.0% in the fourth quarter. New York State Teachers Retirement System now owns 75,215 shares of the company's stock valued at $1,197,000 after purchasing an additional 2,921 shares during the last quarter. 95.17% of the stock is owned by institutional investors.

Avanos Medical Stock Performance

AVNS stock traded down $0.17 during trading on Friday, reaching $12.32. 361,531 shares of the stock were exchanged, compared to its average volume of 361,271. Avanos Medical, Inc. has a twelve month low of $11.84 and a twelve month high of $25.36. The company has a market capitalization of $569.49 million, a P/E ratio of 36.22 and a beta of 1.13. The stock has a 50 day simple moving average of $13.01 and a 200-day simple moving average of $15.49. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12.

Avanos Medical (NYSE:AVNS - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, topping analysts' consensus estimates of $0.19 by $0.07. The business had revenue of $167.50 million for the quarter, compared to the consensus estimate of $161.75 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. The firm's revenue for the quarter was up .8% compared to the same quarter last year. During the same period last year, the business earned $0.22 earnings per share. As a group, sell-side analysts anticipate that Avanos Medical, Inc. will post 1.32 earnings per share for the current year.

Insiders Place Their Bets

In other news, SVP Kerr Holbrook sold 7,000 shares of Avanos Medical stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the transaction, the senior vice president now owns 82,047 shares in the company, valued at approximately $1,251,216.75. The trade was a 7.86% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 2.64% of the company's stock.

Analysts Set New Price Targets

Separately, Wall Street Zen raised Avanos Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, March 19th.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.